CALIXAR, the French biotech company specialized in the native isolation of membrane therapeutic targets/antigens and the French University of Avignon – Bio-organic Chemistry and Amphiphilic Systems Team (CBSA) – announce new grant approval for the CHEM2STAB common laboratory (CHEMistry for STABilization) from the French National Research Agency (ANR).
This new funding will enable CHEM2STAB to intensify efforts in the development of new chemical molecules able to extract and stabilize membrane therapeutic targets without denaturation, and also promoting their crystallization. It does also highlight the high relevance of such initiative for Drug Discovery.
CHEM2STAB is a unique laboratory in the world gathering high-level competencies in chemistry, physical chemistry, biochemistry and structural biology.
Visit Chem2Stab Website